105 related articles for article (PubMed ID: 16116499)
1. Prognostic value of microvessel density, matrix metalloproteinase-9 and p53 protein expression in esophageal cancer.
El-Shahat M; Lotfy M; Fahmy L; Abouel-Nour MF; El-Kenawy Ael-M
J Egypt Natl Canc Inst; 2004 Dec; 16(4):224-30. PubMed ID: 16116499
[TBL] [Abstract][Full Text] [Related]
2. Significance of matrix metalloproteinase 9 and CD34 expressions in esophageal carcinoma: correlation with DNA content.
El-Kenawy Ael-M; Lotfy M; El-Kott A; El-Shahat M
J Clin Gastroenterol; 2005 Oct; 39(9):791-4. PubMed ID: 16145342
[TBL] [Abstract][Full Text] [Related]
3. Clinical prognostic values of vascular endothelial growth factor, microvessel density,and p53 expression in esophageal carcinomas.
Ahn MJ; Jang SJ; Park YW; Choi JH; Oh HS; Lee CB; Paik HK; Park CK
J Korean Med Sci; 2002 Apr; 17(2):201-7. PubMed ID: 11961303
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between expression of matrix metalloproteinase-2 and angiogenesis in esophageal carcinoma].
Li JR; Qi FY; Li L
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):96-8. PubMed ID: 15946548
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer.
Ishikawa S; Takenaka K; Yanagihara K; Miyahara R; Kawano Y; Otake Y; Hasegawa S; Wada H; Tanaka F
Clin Cancer Res; 2004 Oct; 10(19):6579-85. PubMed ID: 15475447
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.
Franchi A; Santucci M; Masini E; Sardi I; Paglierani M; Gallo O
Cancer; 2002 Nov; 95(9):1902-10. PubMed ID: 12404284
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role.
Miyata Y; Iwata T; Maruta S; Kanda S; Nishikido M; Koga S; Kanetake H
Eur Urol; 2007 Sep; 52(3):791-7. PubMed ID: 17207914
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Sharma R; Chattopadhyay TK; Mathur M; Ralhan R
Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer.
Harvey SR; Hurd TC; Markus G; Martinick MI; Penetrante RM; Tan D; Venkataraman P; DeSouza N; Sait SN; Driscoll DL; Gibbs JF
Clin Cancer Res; 2003 Oct; 9(13):4935-43. PubMed ID: 14581368
[TBL] [Abstract][Full Text] [Related]
11. Expression of Matrix Metalloproteinase-9 and CD34 in Giant Cell Tumor of Bone.
Zhou X; Liu XZ; Fan GT; Wu SJ; Zhao JN; Shi X
Orthop Surg; 2016 May; 8(2):220-5. PubMed ID: 27384731
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of angiogenic cytokines in childhood Hodgkin lymphoma.
Citak EC; Oguz A; Karadeniz C; Akyurek N
Pathol Res Pract; 2008; 204(2):89-96. PubMed ID: 18207652
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
16. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
[TBL] [Abstract][Full Text] [Related]
17. Expressions of Inhibitors of DNA Binding-1 and Matrix Metalloproteinase-9 in Colorectal Adenocarcinoma Tissues and Their Correlations with Microvessel Density.
Wu XL; Xue J; Wang LK; Yang DD; Qu M; Guo F; Sun GY; Han L; Yang RM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):696-701. PubMed ID: 28065236
[TBL] [Abstract][Full Text] [Related]
18. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma.
Ishibashi Y; Matsumoto T; Niwa M; Suzuki Y; Omura N; Hanyu N; Nakada K; Yanaga K; Yamada K; Ohkawa K; Kawakami M; Urashima M
Cancer; 2004 Nov; 101(9):1994-2000. PubMed ID: 15372476
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas.
Kitadai Y; Amioka T; Haruma K; Tanaka S; Yoshihara M; Sumii K; Matsutani N; Yasui W; Chayama K
Int J Cancer; 2001 Sep; 93(5):662-6. PubMed ID: 11477575
[TBL] [Abstract][Full Text] [Related]
20. Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma.
Sun MH; Han XC; Jia MK; Jiang WD; Wang M; Zhang H; Han G; Jiang Y
World J Gastroenterol; 2005 Oct; 11(38):5931-7. PubMed ID: 16273602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
